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Abstract: Torsades de pointes (TdP) is a rare but hazardous ventricular dysrhythmia caused by an increase in the QT
interval of the heart rhythm and is categorized into congenital or acquired types. Signs and symptoms of TdP
include syncope, seizure, ventricular fibrillation, and even sudden death. According to statistics, among these
symptoms, syncope and the seizure can be considered as signs that make the TdP diagnosis difficult. Here, we
present an infant referring to Vali-e-Asr Hospital in Birjand with frequent seizures and aspiration pneumonia.
She was diagnosed with Torsades de Pointes and a medium-sized patent ductus arteriosus, and subsequently
underwent a patent ductus arteriosus ligation.
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1. Introduction:
Torsades de Pointes (TdP) is polymorphic ventricular tachy-
cardia (VT) that occurs in the setting of a long-QT inter-
val (QT> 440 ms) and is characterized by a waxing and
waning QRS amplitude(1). Among the factors that can
contribute to increased QT interval and TdP incidence in
patients are female sex, electrolyte disorders such as hy-
pokalemia, hypomagnesaemia and hypocalcaemia, digitalis
consumption, congestive heart failure and heart diseases,
excessive or unbalanced consumption of some cardiovas-
cular and non-cardiac drugs, cocaine abuse, as well as ge-
netic problems such as abnormalities in cardiac ion chan-
nels such as sodium and potassium channels(2-6). In these
patients, certain genetic tests are performed on the patient
and his/her family to diagnose the cause of this dysrhyth-
mia. Several clinical panels, in addition to electrocardiogram
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examination, can be found in patients with TdP, which can
include heart palpitation, syncope, and seizure (7, 8). In
the following case, we study an infant who was referred to
Vali-e-Asr Hospital in Birjand with frequent seizures and as-
pirations and was diagnosed with TdP and a medium-sized
patent ductus arteriosus (PDA) and subsequently underwent
a reconstructive surgery.
2. Case presentation:
The case was a 15-month-old infant girl weighing 10 kg who
was referred to Vali-e-Asr Hospital, Birjand, Iran, as a result
of severe respiratory distress and seizure. At the time of vis-
iting the residency hospital, the infant had an apnea and a
heart attack, for which a cardiac massage was performed and
the patient was referred to Birjand city due to an aspiration
pneumonia and seizure. Physical examination of the height
and weight indicated normal development and head circum-
ference.
According to the statements of the patient’s companion, the
infant had suffered from seizures several times, one of which
occurred at the emergency room and was characterized by
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cyanosis in the face and lips. Considering the examinations
performed in the emergency department showing 50% O2
saturation without oxygen therapy, reduced consciousness
in the patient, and the information from history, the patient
was diagnosed with seizure and was accordingly transferred
to pediatric intensive care unit (PICU) with cardiac monitor-
ing.
After a few hours of monitoring, the patient suffered repeated
VT attacks (Fig 1). Therefore, medication was infused within
20 minutes, including 500 mg magnesium sulfate and 10
mg lidocaine, and VT was discontinued. Furthermore, con-
duction of a 24-hour Holter electrocardiography (ECG) and
echocardiography were put on the agenda. Contrary to ex-
pectations, after taking antiarrhythmic drugs two days after
the first arrhythmia and VT, the patient again suffered ar-
rhythmia as repeated PVC followed by VT; therefore, lido-
caine and magnesium sulfate were administered. However,
even despite the 20-minute infusion of these two drugs, VT
did not stop. Finally, 50 mg of amiodarone was administered
in 30 minutes with a D2 long check before and after the infu-
sion.
After a 24-hour Holter ECG monitoring, long QT intervals
(QT = 490 ms) and VT were observed (Fig 2). Given the in-
dication of the occurrence of TdP in the patient, treatment
with beta-blockers (propranolol) was initiated and all other
anti-arrhythmic drugs were discontinued. Ultimately, ar-
rhythmia of the patient was completely controlled. Further-
more, the patient’s echocardiography showed left atrial en-
largement, left ventricular enlargement, left-to-right shunt,
and PDA with a mean diameter of 4 mm.
Also, all values were within the normal range in terms
of patient-requested tests, including CBC (Complete
Blood Count), natrium, potassium, calcium, magnesium,
Blood Urea nitrogen (BUN), creatinine, Free T4, thyroid-
stimulating hormone (TSH), and Venous Blood Gas (VBG).
Given the size of the PDA, surgery was subsequently pro-
posed for the infant, and the patient underwent thoracotomy
and PDA ligation whereby the patient’s PDA was closed. Pro-
pranolol was discontinued and not used over the course of
6-month, one-year, and two-year periodic follow-ups, and
the patient was asymptomatic. Also, a list of the drugs that
contributed to the arrhythmia was given to the patient to
avoid consumption.
3. Discussion
In some heart diseases, loss of consciousness has movements
similar to seizures that can be indicated in clinical examina-
tions. It is believed that the appearance of these symptoms,
due to the transient cerebral hypoxia in these patients, re-
sults from a temporary reduction of the cardiac output (9,
10). According to recent studies, the probability of misdiag-
Figure 1: Electrocardiogram trace of the patient when dysrhythmia
occurred (Torsade de Pointes).
Figure 2: 24-hour-ECG Holter monitoring with long QTC showing
polymorphic ventricular tachycardia (Torsade de Pointes).
nosis of seizure for a patient is 20%, and cardiovascular fac-
tors including syncope and arrhythmias are often neglected
in these cases, indicating the difficulty of differential diag-
nosis of seizure and TdP in clinical examinations (11-14).
Therefore, ECG and cardiac monitoring are advisable in peo-
ple who have had seizures for the first time. Also, taking a
precise history of the patient, a family history of premature
death under 30 years of age, observation and clinical exami-
nation, and the use of ECG can be helpful in the differential
diagnosis of seizures and seizure-induced cardiovascular dis-
eases(13).
Moreover, since many drugs are involved in TdP incidence,
it is therefore necessary to be mindful of prescribing drugs
for individuals with a possibility of misdiagnosis. It is also
necessary to check the history of TdP stimulant drugs in this
group. In case of unavoidable use of TdP stimulant drugs,
it will provide a more accurate assessment if a set of mea-
sures are taken, including a baseline assessment and a 12-
lead ECG, detailed examination at different times of the day,
and/or Holter monitoring in cases with high possibility of
TdP incidence. It will be helpful for the patient to provide
a list of precautionary measures and risk factors (including
QT interval prolongers) and to prohibit him/her from using
similar drugs that can increase the QT interval. Moreover,
preventing other contributors to increased QT interval such
as electrolyte disorders in these patients is very important (5,
15).
Given the fact that our case was a candidate for PDA closure,
careful consideration was given to use of medications dur-
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ing surgery. The anesthesiologist and the surgical team were
provided with information to prevent the use of prolonged
QT medications and recurrent VT attacks during surgery.
Moreover, regarding the results of genetic tests in patients,
it should be noted that in 80% of the trials, those having
matched clinical features have a confirmed genetic disor-
der. Despite recommendations given to the parents of our
case, these tests were not performed on the patient. More-
over, if mutations are confirmed in the series of genes exam-
ined in this regard, it is necessary to perform these tests on
other family members of the patient, who are asymptomatic.
Should the tests be positive, the family members should take
precautions in terms of taking medications and paying more
attention to certain signs, such as seizures and syncope (8).
4. Conclusion:
The incidence of arrhythmias in children is uncommon, and
when occurring, they may present with misleading signs.
Therefore, the familiarity and mental preparedness of gen-
eral practitioners and pediatricians with these diseases seem
necessary in order to prevent fatal consequences with rapid
diagnosis and timely treatment.
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